| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Isoform Bcl-X(L) of Bcl-2-like protein 1 (Bcl-xL) |
|---|
| Ligand | BDBM109233 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | AlphaScreen Assay (AS) |
|---|
| pH | 7.4±n/a |
|---|
| Temperature | 298.15±n/a K |
|---|
| IC50 | 24±11 nM |
|---|
| Comments | extracted |
|---|
| Citation |  Lessene, G; Czabotar, PE; Sleebs, BE; Zobel, K; Lowes, KN; Adams, JM; Baell, JB; Colman, PM; Deshayes, K; Fairbrother, WJ; Flygare, JA; Gibbons, P; Kersten, WJ; Kulasegaram, S; Moss, RM; Parisot, JP; Smith, BJ; Street, IP; Yang, H; Huang, DC; Watson, KG Structure-guided design of a selective BCL-X(L) inhibitor. Nat Chem Biol9:390-7 (2013) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Isoform Bcl-X(L) of Bcl-2-like protein 1 (Bcl-xL) |
|---|
| Name: | Isoform Bcl-X(L) of Bcl-2-like protein 1 (Bcl-xL) |
|---|
| Synonyms: | B-cell lymphoma-extra large protein (Bcl-xL) | B2CL1_HUMAN | BCL-xL | BCL2L | BCL2L1 | BCLX | Bcl-2-like protein 1 (Bcl-xL) | Isoform Bcl-X(L) |
|---|
| Type: | Homodimers/heterodimers with BAX, BAK and BCL2 |
|---|
| Mol. Mass.: | 26053.63 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_510901 |
|---|
| Residue: | 233 |
|---|
| Sequence: | MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLA
DSPAVNGATAHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAY
QSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEP
WIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK
|
|
|
|---|
| BDBM109233 |
|---|
| n/a |
|---|
| Name | BDBM109233 |
|---|
| Synonyms: | 2-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)thiazole-4-carboxylic acid (Compound 4) | CHEMBL2398260 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H16N4O2S2 |
|---|
| Mol. Mass. | 420.507 |
|---|
| SMILES | OC(=O)c1csc(n1)-c1ccc2CCCC(=NNc3nc4ccccc4s3)c2c1 |w:16.17| |
|---|
| Structure | 
|
|---|
Search and Browse
